Menorrhagia in Women After the Administration of Novel Oral ‎Anticoagulants, Like Rivaroxaban: A Case Report

Background: The Novel Oral Anticoagulants (NOACs), despite numerous benefits, such as the ease of use and less drug involvement, provide extensive adverse effects. One of the most significant, but rare side effects of them in women is severe and dangerous bleeding. Case presentation: In this study, we reported a case of severe vaginal bleeding (manometric hemorrhage) in a woman receiving rivaroxaban to prevent pulmonary thrombosis. Conclusion: The oral anticoagulant rivaroxaban could present a rare adverse effect on women.

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717962318.793465537 ◽

2012 ◽

Author(s):

Jack Kron ◽

Eric Stecker

Keyword(s):

Atrial Fibrillation ◽

Systematic Review ◽

Meta Analysis ◽

Oral Anticoagulants ◽

Novel Oral Anticoagulants ◽

The Novel ◽

Efficacy And Safety

Download Full-text

Management of Vipadika with Mahisha Gritha Padanimajjana – a case report

Journal of Complementary and Integrative Medicine ◽

10.1515/jcim-2020-0173 ◽

2021 ◽

Vol 0 (0) ◽

Author(s):

Sharanya Suseela ◽

Anandaraman Puthanmadom Venkatraramana Sharma ◽

Kesavan Parameswaran Namboothiri ◽

Prathibha Changuli Krishna Bhat

Keyword(s):

Case Report ◽

Side Effects ◽

Effective Treatment ◽

Skin Disorder ◽

Severe Pain ◽

Case Presentation ◽

Treatment Methods ◽

Treatment Line ◽

Short Period ◽

Ayurvedic Treatment

Abstract Objectives Vipadika (Palmo plantar Psoriasis) is a Kshudra Kushta (minor skin disorder) of Vatakapha origin (body humors like vata and kapha) characterized by Sphutana (cracks) and Teevra Vedana (severe pain) in Pani (palm) and Pada (sole). Based on the symptoms it can be correlated to Palmo Plantar Psoriasis which is a variant of psoriasis which affects the skin of the palms and soles with the features of hyperkeratotic, pustular, or mixed morphologies. The treatment methods for Palmo plantor psoriasis causes severe side effects due to which an evident shift from modern treatments to ayurvedic treatment line. Case presentation A 15 year old, female, with complaint of cracks and dryness over sole of both feet with pain for the last 12 and half years. The case was managed with Padanimajjana (immersion of foot). Padanimajjana is a modified form of Avagaha Sweda (switz bath) where the affected part of the foot is dipped in medicated liquid. Here Mahisha Gritha (Buffaloe ghee) is used for Padanimajjana. Conclusions Mahisha Gritha Padanimajjana shows significant improvement in number of cracks, dryness and pain within short period of time. This is a very simple, economical, and effective treatment for Vipadika.

Download Full-text

Could the Novel Oral Anticoagulants Be Used for Coronary Artery Aneurysm?

Case Reports in Medicine ◽

10.1155/2020/5073814 ◽

2020 ◽

Vol 2020 ◽

pp. 1-4

Author(s):

Quanxiang Yan ◽

Libing Ning ◽

Yu Jian ◽

Wencong Yang ◽

Qinghua Yuan ◽

...

Keyword(s):

Coronary Artery ◽

Coronary Angiography ◽

Coronary Artery Aneurysm ◽

Left Main Coronary Artery ◽

Oral Anticoagulants ◽

Artery Aneurysm ◽

Antiplatelet Agents ◽

Novel Oral Anticoagulants ◽

The Novel ◽

Coronary Artery Aneurysms

Coronary artery aneurysms (CAAs) are uncommon in coronary angiography, and left main coronary artery aneurysms are rare. There is no consensus for the treatment of CAAs. A young patient with left coronary artery aneurysm diagnosed by coronary angiography and with recurrent acute myocardial infarction was treated with rivaroxaban and aspirin. The patient had no angina for 6 months. Novel oral anticoagulants combined with antiplatelet agents may be appropriate for the treatment of CAAs.

Download Full-text

Atrial fibrillation in athletes: From epidemiology to treatment in the novel oral anticoagulants era

Journal of Cardiology ◽

10.1016/j.jjcc.2018.04.011 ◽

2018 ◽

Vol 72 (4) ◽

pp. 269-276 ◽

Cited By ~ 5

Author(s):

Giuseppe D. Sanna ◽

Eleonora Gabrielli ◽

Elena De Vito ◽

Giuseppe Nusdeo ◽

Domenico Prisco ◽

...

Keyword(s):

Atrial Fibrillation ◽

Oral Anticoagulants ◽

Novel Oral Anticoagulants ◽

The Novel

Download Full-text

Would you use novel oral anticoagulants (NOACs) for thromboprophylaxis in patients with an underlying hypercoagulable state? A literature review through a case report

BMJ Case Reports ◽

10.1136/bcr-2020-237238 ◽

2020 ◽

Vol 13 (10) ◽

pp. e237238

Author(s):

Bhavika Kakadia ◽

Giselle Alexandra Suero-Abreu ◽

Rrita Daci ◽

Ryna Karina Then

Keyword(s):

Case Report ◽

Literature Review ◽

Arterial Thrombosis ◽

Case Reports ◽

Oral Anticoagulants ◽

Novel Oral Anticoagulants ◽

Current Evidence ◽

Multiple Drug ◽

Autoimmune Condition ◽

Randomised Controlled

Antiphospholipid syndrome (APLS) is an autoimmune condition that predisposes to venous and arterial thrombosis. Warfarin is the agent of choice for anticoagulation. However, a need for routine international normalised ratio (INR) checks and multiple drug interactions are some of the difficulties with warfarin. Currently, there is mixed evidence for and against the use of novel oral anticoagulants (NOACs) for thromboprophylaxis. We present a case report of a patient with APLS on a NOAC for secondary thromboprophylaxis who developed a stroke and discuss current evidence regarding the use of NOACs in patients with APLS. The patient was switched to warfarin for secondary thromboprophylaxis with an INR goal of 2–3. Literature review revealed mixed case reports for and against NOACs for secondary prevention of thrombotic events in patients with APLS. There needs to be further randomised controlled trials to evaluate the efficacy of NOACs for thromboprophylaxis in patients with APLS.

Download Full-text